Schedule 13G ownership disclosure

EIGER BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 28249U105

Event date: 2017-08-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-17-002500
Form type
SC 13G
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Aug 22, 2017
Reporting period
Aug 17, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub